Dauty M, Menu P, Fouasson-Chailloux A, Dubois C
Service de MPR locomoteur, hôpital Saint-Jacques, CHU de Nantes, 85, rue Saint-Jacques, 44035 Nantes cedex 01, France.
Service de MPR locomoteur, hôpital Saint-Jacques, CHU de Nantes, 85, rue Saint-Jacques, 44035 Nantes cedex 01, France.
Ann Phys Rehabil Med. 2014 Feb;57(1):55-65. doi: 10.1016/j.rehab.2013.10.005. Epub 2013 Nov 16.
Thirty-nine revision of ACL reconstructions were evaluated: 23 primary ACL reconstructions with bone-patellar tendon-bone graft (BPTB) revised with hamstring tendon (HT) grafts, 10 primary ACL reconstructions with HT grafts revised with ipsilateral BPTB graft (iBPTB) and finally 6 primary ACL reconstructions with BPTB grafts revised with contralateral BPTB (cBPTB) grafts were compared with 78 primary ACL reconstructions (46 HT grafts and 32 BPTB grafts). Recovery of isokinetic muscle strength was evaluated at 4, 6 and 12 months post-revision surgery.
Deficits in muscle strength at 12 months post-revision ACL surgery were comparable to the one observed for primary ACL reconstruction with the same technique. At 4 and 6 months post-surgery, strength deficits for the knee extensors were less pronounced after revision ACL reconstruction with HT grafts (25%±16 vs. 37%±16; P<0.001) and iBPTB grafts (41%±11 vs. 17%±17; P<0.001).
Lower strength deficits for the knee extensors after revision ACL reconstruction with HT grafts can be explained by a less intensive rehabilitation program due to lower stakes in resuming sport activities. With cBPTB, donor-site morbidity could explain the decreased strength deficits for knee extensors.
Deficits in isokinetic muscle strength after ACL revision seem similar to the ones observed after primary ACL reconstruction with the same surgical technique.
对39例前交叉韧带(ACL)重建翻修病例进行评估:23例初次ACL重建采用骨-髌腱-骨移植物(BPTB),后用腘绳肌腱(HT)移植物进行翻修;10例初次ACL重建采用HT移植物,后用同侧BPTB移植物(iBPTB)进行翻修;最后6例初次ACL重建采用BPTB移植物,后用对侧BPTB(cBPTB)移植物进行翻修,并与78例初次ACL重建病例(46例HT移植物和32例BPTB移植物)进行比较。在翻修手术后4、6和12个月评估等速肌力恢复情况。
ACL翻修手术后12个月的肌力缺损与采用相同技术的初次ACL重建所观察到的情况相当。在术后4和6个月,采用HT移植物(25%±16 vs. 37%±16;P<0.001)和iBPTB移植物(41%±11 vs. 17%±17;P<0.001)进行ACL翻修重建后,膝关节伸肌的力量缺损不太明显。
采用HT移植物进行ACL翻修重建后膝关节伸肌力量缺损较低,这可以用恢复体育活动的风险较低从而康复计划强度较小来解释。对于cBPTB,供区并发症可以解释膝关节伸肌力量缺损的降低。
ACL翻修术后等速肌力缺损似乎与采用相同手术技术的初次ACL重建后所观察到的缺损相似。